n | Sensitivity (95% CI) | Specificity (95% CI) | NPV | PPV | Accuracy | |
All | 169 | 0.93 (0.86–0.96) | 1.0 (0.95–1.0) | 0.91 | 1 | 0.96 |
Sex | ||||||
Male | 55 | 0.82 (0.68–0.96) | 1.0 (0.88–1.0) | 0.84 | 1 | 0.90 |
Female | 114 | 0.93 (0.87–0.99) | 1.0 (0.91–1.0) | 0.89 | 1 | 0.96 |
Age | ||||||
>50 years | 95 | 0.94 (0.89–0.99) | 1.0 (0.87–1.0) | 0.87 | 1 | 0.96 |
≤50 years | 74 | 0.81 (0.67–0.95) | 1.0 (0.92–1.0) | 0.87 | 1 | 0.92 |
Diagnosis | ||||||
PVD | 49 | 0.94 (0.84–0.98) | 1.0 (0.95–1.0) | 0.92 | 1 | 0.95 |
LHD | 52 | 0.92 (0.82–0.97) | 1.0 (0.95–1.0) | 0.94 | 1 | 0.97 |
#: The test was considered positive only if both criteria mPAPmax >30 mmHg and TPRmax >3 WU were satisfied. mPAPmax: mean pulmonary artery at maximal exercise; TPRmax: total pulmonary resistance at maximal exercise; NPV: negative predictive value; PPV: positive predictive value; PVD: pulmonary vascular disease; LHD: left heart disease.